Fear-not clinical indications-may be the driving force in women's decision-making about contralateral prophylactic mastectomy (CPM). That is the surprising conclusion from a population-based study presented by investigators from Michigan at the 2012 American Society of Clinical Oncology (ASCO) Quality Symposium in San Diego.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.